# Randomized Study on Neoadjuvant Radio-Chemotherapy in Rectal Carcinoma Dukes B and C

> **NCT00309517** · PHASE3 · TERMINATED · sponsor: **Austrian Breast & Colorectal Cancer Study Group** · enrollment: 700 (—)

## Conditions studied

- Rectal Cancer Dukes B, Dukes C

## Interventions

- **DRUG:** Fluourouracil
- **DRUG:** Leucovorin
- **DRUG:** MAb 17-1A

## Key facts

- **NCT ID:** NCT00309517
- **Lead sponsor:** Austrian Breast & Colorectal Cancer Study Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1997-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 700 (—)
- **Last updated:** 2006-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00309517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00309517, "Randomized Study on Neoadjuvant Radio-Chemotherapy in Rectal Carcinoma Dukes B and C". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00309517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*